卵巢癌可切除性腹腔镜评估:10步标准化流程
本文介绍用于疑似晚期卵巢癌开腹术前评估的10步标准化腹腔镜流程,按解剖顺序系统探查并记录腹膜癌指数(PCI)全部12个区域,并采用Sugarbaker PCI、Fagotti评分和Makar分型判断可切除性。流程强调早期腹膜细胞学、4–6处10-mm冷刀宽活检及大网膜活检优先,避免近空腔脏器活检,以支持治疗决策并减少延误和重复手术。
要点
- 采用严格中线入路,系统探查并按PCI 12区域拍照记录。
- 用Sugarbaker PCI、Fagotti评分和Makar分型评估可切除性。
- 早期腹膜细胞学,至少4–6处10-mm冷刀宽活检,优先大网膜活检。
核心结论
- 标准化的10步腹腔镜流程可提高疑似晚期卵巢癌可切除性评估的诊断质量,并支持及时制定治疗决策。
研究设计与样本
- 视频摘要介绍针对疑似晚期卵巢癌、在确定初始治疗策略前接受诊断性腹腔镜患者的标准化探查序列。
主要发现
- 10步包括穿刺器放置、腹膜细胞学与腹水定量、上腹部探查、大网膜与横结肠评估、小肠与肠系膜探查、双髂窝与盆腔评估,最后拍照记录并活检。
- 采用Sugarbaker PCI、Fagotti评分和Makar分型三种验证工具评估可切除性。
- 推荐至少4–6处10-mm冷刀宽活检,优先大网膜活检用于组织学和分子分析,避免近肠管和膀胱活检。
关键数值与推荐
- 按腹膜癌指数(PCI)全部12个区域进行拍照记录。
- 至少获取4–6处宽10-mm活检。
临床怎么用
- 在疑似晚期卵巢癌初始治疗决策前实施该10步腹腔镜流程,以指导选择完全肿瘤细胞减灭术或新辅助化疗。
- 在专家中心与周边合作医院推广标准化流程,以统一分期实践并减少治疗延误。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Exploratory laparoscopy plays a critical role in assessing resectability in suspected advanced-stage ovarian cancer. Performed early, it guides treatment toward either complete cytoreductive surgery or neoadjuvant chemotherapy. With the implementation of B5 accreditation for expert centers, a French national certification system designating specialized oncologic referral centers, peripheral hospitals are becoming key actors in diagnosis and staging. A well-conducted laparoscopy avoids delays and repeat procedures, thereby improving patient outcomes. This study presents a 10-step laparoscopic protocol that is anatomically ordered, simple, and reproducible, facilitating adoption across both expert and partner centers. SETTING: Women undergoing initial assessment for suspected advanced-stage ovarian cancer prior to therapeutic decision-making. PARTICIPANTS: Patients with suspected advanced-stage ovarian cancer referred for diagnostic laparoscopy before determination of the initial treatment strategy. INTERVENTIONS: This video outlines a standardized exploratory sequence using a strict midline laparoscopic approach (single supraumbilical trocar or two aligned trocars). Each of the 12 regions of the Peritoneal Cancer Index (PCI) is documented photographically. Resectability is assessed using three validated tools: Sugarbaker's PCI, the Fagotti score, and the Makar classification. CONCLUSION: The 10 steps include: trocar placement; peritoneal cytology with ascites quantification; inspection of the upper abdomen (right and left diaphragmatic domes, liver, spleen); evaluation of the omentum and transverse colon; exploration of the small bowel and mesentery (Trendelenburg); assessment of both iliac fossae and the pelvis; followed by photographic documentation and biopsies. Key elements include early peritoneal cytology and at least four to six wide (10-mm) biopsies obtained using cold scissors. Epiploic biopsy is prioritized for histologic and molecular analysis. Biopsies near hollow organs (bowel, bladder) are avoided to reduce procedural complications. The standardized 10-step sequence is summarized in Annexe 1 to facilitate reproducibility and clinical adoption. This reproducible and structured 10-step approach strengthens the role of partner centers in advanced ovarian cancer care. It improves diagnostic quality, harmonizes staging practices, and supports timely, expert-level treatment planning. Widespread adoption may reduce disparities and promote equitable care. VIDEO ABSTRACT.
引用
- Chabert C, Djemouai S, Rambeaud C, et al. Laparoscopic Assessment of Resectability in Ovarian Cancer: A 10-Step Standardized Approach. J Minim Invasive Gynecol. 2026. PMID: 41887399. doi:10.1016/j.jmig.2026.03.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。